Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
01 2022
Historique:
received: 18 05 2021
revised: 06 10 2021
accepted: 13 10 2021
pubmed: 24 10 2021
medline: 15 12 2021
entrez: 23 10 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has highlighted the need for generic reagents and flexible systems in diagnostic testing. Magnetic bead-based nucleic acid extraction protocols using 96-well plates on open liquid handlers are readily amenable to meet this need. Here, one such approach is rigorously optimized to minimize cross-well contamination while maintaining sensitivity.

Identifiants

pubmed: 34687784
pii: S0166-0934(21)00278-0
doi: 10.1016/j.jviromet.2021.114339
pmc: PMC8527638
pii:
doi:

Substances chimiques

Indicators and Reagents 0
Nucleic Acids 0
RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114339

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Sci Rep. 2017 Mar 23;7:45199
pubmed: 28332631
RNA. 2020 Jul;26(7):771-783
pubmed: 32358057
Viruses. 2020 Aug 07;12(8):
pubmed: 32784757

Auteurs

Simon Haile (S)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Aidan M Nikiforuk (AM)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Pawan K Pandoh (PK)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

David D W Twa (DDW)

BC Cancer Research Centre, BC Cancer, Vancouver, British Columbia, Canada.

Duane E Smailus (DE)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Jason Nguyen (J)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.

Stephen Pleasance (S)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Angus Wong (A)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Yongjun Zhao (Y)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Diane Eisler (D)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.

Michelle Moksa (M)

Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.

Qi Cao (Q)

Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.

Marcus Wong (M)

Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.

Edmund Su (E)

Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.

Martin Krzywinski (M)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Jessica Nelson (J)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Andrew J Mungall (AJ)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Frankie Tsang (F)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.

Leah M Prentice (LM)

Provincial Laboratory Medicine Services, Provincial Health Services Authority, Vancouver, British Columbia, Canada.

Agatha Jassem (A)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Amee R Manges (AR)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.

Steven J M Jones (SJM)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Robin J Coope (RJ)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.

Natalie Prystajecky (N)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Marco A Marra (MA)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Mel Krajden (M)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Martin Hirst (M)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada; Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: hirstm@mail.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH